Background: Alzheimer's disease (AD) is generally thought to spare primary sensory function; however, such interpretations have drawn from a literature that has rarely taken into account the variable cognitive declines seen in patients with AD. As these cognitive domains are now known to modulate cortical somatosensory processing, it remains possible that abnormalities in somatosensory function in patients with AD have been suppressed by neuropsychological variability in previous research. Methods: In this study, we combine magnetoencephalographic (MEG) brain imaging during a paired-pulse somatosensory gating task with an extensive battery of neuropsychological tests to investigate the influence of cognitive variability on estimated differences in somatosensory function between biomarker-confirmed patients on the AD spectrum and cognitively-normal older adults. Findings: We show that patients on the AD spectrum exhibit largely non-significant differences in somatosensory function when cognitive variability is not considered (p-value range: .020À.842). However, once attention and processing speed abilities are considered, robust differences in gamma-frequency somatosensory response amplitude (p < .001) and gating (p = .004) emerge, accompanied by significant statistical suppression effects. Interpretation: These findings suggest that patients with AD exhibit insults to functional somatosensory processing in primary sensory cortices, but these effects are masked by variability in cognitive decline across individuals.
Background Despite decades of research suggesting that primary somatosensory cortical function is spared until relatively late in the progression of Alzheimer’s disease (AD), very few of these studies have considered the role of domain‐specific cognitive function. This is essential, as recent literature has established a robust neurocognitive relationship between attention and executive functions and somatosensory neurophysiology, and patients with AD exhibit highly variable inter‐individual declines in these cognitive domains. Method In this study, we combine the high spatio‐temporal resolution of source imaged magnetoencephalography (MEG) with an extensive battery of neuropsychological tests to examine the potential mediating role of domain‐specific cognitive declines on somatosensory neural dysfunction in AD. In a sample of 38 biomarker‐confirmed patients on the AD spectrum and a group of 18 biomarker‐negative older adults, we model mediation/suppression effects of five distinct cognitive composite domains on group differences in two neurophysiological metrics of somatosensory function using a nonparametric bootstrapping approach. Result Initial models that did not consider cognitive abilities provided weak or null support for somatosensory dysfunction in patients on the AD spectrum. However, the addition of domain‐specific cognitive scores to these models significantly increased their predictive capacity, and revealed robust differences in somatosensory function between these patients and their cognitively‐normal counterparts. The indirect effects of these cognitive variables on somatosensory group differences were significant as well, indicating a suppression effect. Specifically, across‐participant variability in processing speed declines was found to mask groupwise differences in mean somatosensory response amplitude, and similar variability in both processing speed and attention function was found to mask differences in the functional gating of redundant somatosensory information. Conclusion By considering an important potential confounder in our models of somatosensory dysfunction in patients on the AD spectrum, we show that both general somatosensory responses and the functional gating of incoming somatosensory information exhibit profound alterations in these patients. These findings hold important implications for both our understanding of functional somatosensory pathology in AD, as well as for the importance of considering the role of domain‐specific cognitive variability in future AD‐neuroimaging research.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.